ISTA PHARMACEUTICALS INC Increase (Decrease) in Royalties Payable
ISTA PHARMACEUTICALS INC reported Increase (Decrease) in Royalties Payable of -$19.61 million for the 3-month period ending 2012-03-31, per its 10-Q filed 2012-05-04.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInRoyaltiesPayable · last filed 2012-05-04
- ISTA PHARMACEUTICALS INC increase (decrease) in royalties payable for the quarter ending 2012-03-31 was -$19.61M, a 421.87% decline year-over-year.
- ISTA PHARMACEUTICALS INC increase (decrease) in royalties payable for the quarter ending 2011-12-31 was $1.63M, a 66.85% decline year-over-year.
- ISTA PHARMACEUTICALS INC increase (decrease) in royalties payable for the quarter ending 2011-09-30 was $6.84M, a 4.44% decline year-over-year.
- ISTA PHARMACEUTICALS INC increase (decrease) in royalties payable for the quarter ending 2011-06-30 was $944.00K.
- ISTA PHARMACEUTICALS INC increase (decrease) in royalties payable for fiscal 2011 was $15.51M, a 14.89% decline from fiscal 2010.
- ISTA PHARMACEUTICALS INC increase (decrease) in royalties payable for fiscal 2010 was $18.22M, a 1130.18% increase from fiscal 2009.
- ISTA PHARMACEUTICALS INC increase (decrease) in royalties payable for fiscal 2009 was $1.48M.
| Period end | Increase (Decrease) in Royalties Payable 3 month | Increase (Decrease) in Royalties Payable 6 month | Increase (Decrease) in Royalties Payable 9 month | Increase (Decrease) in Royalties Payable 12 month |
|---|---|---|---|---|
| 2012-03-31 | -$19.61M 10-Q · filed 2012-05-04 | -$17.99M derived: sum of 2 quarters · filed 2012-05-04 | -$11.15M derived: sum of 3 quarters · filed 2012-05-04 | -$10.20M derived: sum of 4 quarters · filed 2012-05-04 |
| 2011-12-31 | $1.63M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $8.47M derived: sum of 2 quarters · filed 2012-02-27 | $9.41M derived: sum of 3 quarters · filed 2012-02-27 | $15.51M 10-K · filed 2012-02-27 |
| 2011-09-30 | $6.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-07 | $7.79M derived: sum of 2 quarters · filed 2011-11-07 | $13.88M 10-Q · filed 2011-11-07 | $18.78M derived: sum of 4 quarters · filed 2012-05-04 |
| 2011-06-30 | $944.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-01 | $7.04M 10-Q · filed 2011-08-01 | $11.94M derived: sum of 3 quarters · filed 2012-05-04 | $19.10M derived: sum of 4 quarters · filed 2012-05-04 |
| 2011-03-31 | $6.09M 10-Q · filed 2012-05-04 | $11.00M derived: sum of 2 quarters · filed 2012-05-04 | $18.16M derived: sum of 3 quarters · filed 2012-05-04 | |
| 2010-12-31 | $4.90M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $12.06M derived: sum of 2 quarters · filed 2012-02-27 | $18.22M 10-K · filed 2012-02-27 | |
| 2010-09-30 | $7.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-07 | $13.32M 10-Q · filed 2011-11-07 | ||
| 2010-06-30 | $6.16M 10-Q · filed 2011-08-01 | |||
| 2009-12-31 | $1.48M 10-K · filed 2012-02-27 |